Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Arber C, Baerlocher G, Chalandon Y, Daskalakis M, Duchosal M, Fehr M, Gerull S, Güngör T, Nair G, Pabst T, Passweg J, Piccolruaz B, Renner C, Rüfer A, Schneidawind D, Stuessi G, Zeerleder S, Halter J, Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group. Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Med Wkly 2024; 154:3704.
Oct 3, 2024
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Oct 3, 2024
Swiss Med Wkly 2024; 154:3704
Arber Caroline, Baerlocher Gabriela M, Chalandon Yves, Daskalakis Michael, Duchosal Michel A, Fehr Martin, Gerull Sabine, Güngör Tayfun, Nair Gayathri, Pabst Thomas, Passweg Jakob R, Piccolruaz Barbara, Renner Christoph, Rüfer Axel, Schneidawind Dominik, Stuessi Georg, Zeerleder Sacha, Halter Jörg P, Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group
more
